Progestin-only contraceptive pill use among women in the United States
- PMID: 22682722
- PMCID: PMC3440515
- DOI: 10.1016/j.contraception.2012.05.003
Progestin-only contraceptive pill use among women in the United States
Abstract
Background: Progestin-only contraceptive pills (POPs) offer a safe and effective contraceptive option, particularly for women at increased risk of venous thromboembolism. However, the prevalence of POP use among women in the United States is unknown.
Study design: We analyzed population-based data from 12,279 women aged 15-44 years in the National Survey of Family Growth. Data were collected continuously from 2006 to 2010 by in-person, computerized household interviews. Analyses describe POP use across sociodemographic and reproductive characteristics and thromboembolic risk profiles.
Results: Overall, 0.4% of all reproductive-aged women in the United States currently use POPs. POP use was higher among parous, postpartum and breastfeeding women than their counterparts (all p values<.001). Women at higher risk of thromboembolism (older, obese, diabetic or smoking women) had similar proportions of POP use as women without those risks.
Conclusion: POPs are rarely used by US women. While data on chronic disease were limited, our results suggest that relatively few women with increased risk of thromboembolism are considering POPs when choosing an oral contraceptive.
Copyright © 2012 Elsevier Inc. All rights reserved.
References
-
- Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital Health Stat. 2010;23:1–43. - PubMed
-
- Hatcher RA, Trussell J, Nelson A, et al., editors. Contraceptive Technology. 20th revised edition Ardent Media, Inc.; New York: 2011.
-
- World Health Organization . Medical eligibility criteria for contraceptive use. 4th edition (internet) WHO; Geneva: 2009. [January 18, 2012]. Available from http://www.who.int/reproductivehealth/publications/family_planning/97892....
-
- Centers for Disease Control and Prevention U.S. medical eligibility criteria for contraceptive use 2010. MMWR. 2010;59:1–85.
-
- Gomes MP, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med. 2004;164:1965–76. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
